Cardiometabolic Flashcards
(111 cards)
PFCMVPs associated with cardiometabolic disease (4)
Fe, Mg, CoQ10, MUFA/olive oil
from Cardiometabolic decision tree
Treatment considerations for insulin resistance
Cr, Vn (caution re: high dose long term), Mg; berberine, n3-fatty acids, MCT/MCFA, MUFA/olive oil; ALA for peripheral neuropathy, cinnamon
(from Cardiometabolic decision tree)
Treatment considerations for dyslipidemia
C:12 Lauric acid (increases TC & HDL, decreases TC/HDL), B3/B5, EPA/DHA +GLA, berberine, bergamot, garlic, red yeast rice
(from Cardiometabolic decision tree)
Treatment considerations for vascular disease
Mg/K; Arg, BH4, B2; taurine; pomegranate: lycopene, garlic; D3, K2-MK7
(from Cardiometabolic decision tree)
Treatment considerations for autonomic dysfunction
Meditation, breath Rx, biofeedback, HRV, adrenal support
from Cardiometabolic decision tree
Treatment considerations for coagulation disorders
ASA; B6, B12, FA; bromelain; nattokinase; vitamin E
from Cardiometabolic decision tree
Treatment considerations for immune & detox dysregulation
Probiotics, curcumin, quercetin, caloric restriction, vitamins C/E/A, ALA, NAC, resveratrol
(from Cardiometabolic decision tree)
What are some of the physiological interconnections between insulin, inflammation and adipocytes?
Think Gluco- and Lipotoxicity
- Excess nutrition/obesity increases adipocyte mass & death, which in turn increases release of inflammatory adipocytokines (TNF-alpha, IL-6, etc) & drives recruitment of macrophages from bone marrow into fat cells–> inflammation (paracrine response)
- High sugar & fat diet activates also TLR -> activates NF-kB and JNK pathways in adipocytes, hepatocytes and macrophages -> inflammation -> local & systemic insulin resistance
- Insulin resistance leads to fatty and inflamed liver and eventually insulin resistant muscle –> more inflammation
- Microbiome changes also increase leaky gut -> LPS and endotoxemia –> inflammation, inadequate SCFA, and further metabolic dysfunction
(from Dr. Saxena’s “Fire in the Hole” lecture)
What is the paracrine response to obesity, that drives insulin resistance in the adipocytes?
Increased resistin and decreased adiponectin (adipokines), release of pro inflammatory cytokines (TNF-alpha, IL-6, etc), and increased FFA -> leads to insulin resistance & inflammation within adipocyte
(from Dr. Saxena’s “Fire in the Hole” lecture)
What are some causes of insulin resistance?
Poor lifestyle, environmental toxins, mitochondrial dysfunction (b/c decreases insulin production), dysbiosis, altered body composition (increased BMI, WHR, WC, & body fat %), genetic predisposition
(from Dr. Saxena’s “Fire in the Hole” lecture)
What are the conventional “Should know” cardiometabolic lab tests & assessments?
BMI, WC, fasting BG & insulin, A1C, cholesterol or lipoprotein profile, hsCRP, CBC w/differential, homocysteine, GGT, vitamin B12, Mg, vit D25OH, CMP (esp AST, ALT), microalbumin creatinine ratio
What are some components of an expanded lipid panel?
LDL-P size and number, LDL pattern A vs B, HDL 2 vs 3, VLDL size
Modified (oxidized or glycated LDL),
ApoB (protein core of LDL/VLDL -bad), ApoA1 (protein core of HDL - good), ApoB:ApoA1 (target<0.8)
Lp-PLA2 (assoc w/oxLDL, inflammation & progression of atherosclerosis)
TGs, IDL (genetically determined and an independent risk factor), Lp(a)
What are some emerging cardiometabolic risk markers?
Oxidative stress (myeloperoxidase, F2I), CIMT, coronary artery calcium/CAC scoring, trimethylamine-N-oxide (TMAO;gut measure), omega-3 index, ASA resistance, aldosterone:renin ratio (ARR; 40+ suggests low renin HTN, <10 suggests high renin HTN)
How does TMAO respond with increasing CV risk?
Increases (via lipid dysregulation & macrophage function)
What is the relationship of TG level with insulin response?
Increased TG with excess insulin; precedes impaired fasting glucose.
TG/HDL ratio <3=normal; if >/=3 suggests insulin resistance
Which LDL particle pattern is preferred (A vs. B)
A; pattern B occurs with smaller and more dense LDL; increased LDL apo-B
What is the difference between HDL 2 & HDL 3?
HDL 2=large and buoyant (preferred), HDL 3= small & less protective
Which type of VLDL is associated with most risk?
VLDL 3 - most dense (compared to 1&2)
What are some conditions related to cardiometabolic dysfunction outside of CVD?
Obesity, sarcopenia, NAFLD, Type 2 & 3 DM, MetSx; Hormonal - E2 dominance/cancers (breast CA), PCOS, osteoporosis, men - decreased testosterone
How does insulin relate to increased risk of breast CA?
Increased insulin & IGF, decreased adiponectin -> inflammation; also increases estradiol & testosterone, decreases SHBG by increasing aromatase activity (testosterone binds SHBG preferentially)
What anthropometrics can be predictive for breast CA prognosis pre- and post-menopause?
BMI - post-menopausal
WHR - pre-menopause
Can focus on these for prevention
How does insulin relate to hormone changes in PCOS?
Increased insulin in ovaries -> increases testosterone, which binds to SHBG
In the natural history of Type 2 DM, what happens to: insulin resistance & secretion?
post-prandial and fasting glucose?
Insulin resistance increases before diagnosis and levels off
Insulin secretion increases until diagnosis and then decreases
Post-prandial glucose increases gradually then speeds up around diagnosis and beyond
Fasting glucose gradually increases toward diagnosis and beyond (increase is slower that post-prandial)
Note: incretin and B-cell function both declines over time
What are the differences between android obesity & gynoid obesity?
Android - apple shape; over fat, over VAT (visceral adipose tissue); assess w/WC & WHR
Gynoid - pear shape; over fat, over SAT (subcutaneous adipose tissue); assess with BIA (high %body fat, but normal WHR)